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Purpose: To investigate the association in a Thai population between the major age-related 
macular degeneration (AMD) susceptibility loci, Y402H and I62V in the complement factor H 
(CFH) and A69S in the age-related maculopathy susceptibility 2 (ARMS2) genes, and polypoidal 
choroidal vasculopathy (PCV).
Methods: A case-control study included 97 PCV cases and 102 age- and gender-matched 
controls without any retinopathy. The genotypic profiles of the three polymorphisms were 
obtained using a real-time polymerase chain reaction assay. The allelic and genotypic associa-
tion between the polymorphisms and PCV were compared with those from the compiled data 
of other Asian populations reported previously.
Results: Strong associations between the Y402H, I62V, and A69S polymorphisms and PCV were 
observed in the present study (P = 0.002, 0.003, and 0.0008 respectively) and in the compiled data 
(P , 0.0001 for all three polymorphisms). The risk allele frequencies of the polymorphisms in 
PCVs and in controls from the present study (15.0% and 5.4% for Y402H, 71.7% and 57.4% for 
I62V, and 54.1% and 37.3% for A69S respectively) were also comparable with the frequencies 
from the compiled data (10.3% and 6.4% for Y402H, 75.2% and 58.3% for I62V, and 56.8% 
and 36.8% for A69S respectively). The genotype distribution for each polymorphism was also 
comparable in both datasets.
Conclusion: The findings of this study support a significant genetic association between the 
major AMD susceptibility genes and PCV across Asian populations. This suggests that AMD and 
PCV , despite different phenotypic manifestation, may share common genetic risk factors.
Keywords: genetic, association, PCV , age-related macular degeneration, CFH gene, 
ARMS2 gene
Introduction
A significant association between single nucleotide polymorphisms (SNP) and 
age-related macular degeneration (AMD) has been reported in diverse populations 
worldwide.1 The two most common AMD-associated SNPs, the Y402H   polymorphism 
in the complement factor H (CFH) gene on chromosome 1q31 and the A69S 
polymorphism in the age-related maculopathy susceptibility 2 (ARMS2) gene on 
  chromosome 10q26, have been found in Caucasian and Asian populations.2,3 The 
phenotypic manifestation of AMD in a large number of Asian patients, however, are 
different from those in Caucasian patients.4 A variant of the neovascular form of AMD 
in Asians, known as polypoidal choroidal vasculopathy (PCV), has typical characteris-
tics of an abnormal branching vascular network with terminal polypoidal bulbs in inner 
choroids, which are not commonly found in Caucasians.5 This has raised a question of 
whether genotypic manifestations of PCV are different from those of AMD.
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Initial studies on the association between these two genes 
and PCV among Asians have shown contradictory results. 
Although the A69S SNP has been widely found to exhibit 
a strong association with PCV in many Asian populations, 
studies in Japanese, Chinese and Korean populations could 
not find a significant link between Y402H and AMD.6–8 
Interestingly, few studies revealed an association between 
PCV and the I62V polymorphism of another locus in the 
same CFH gene. Recent studies in a Japanese population and 
a cohort of subjects of European-American descent in the 
United States, however, have shown a strong association 
between Y402H and PCV .9,10
The majority of these data have been obtained from East 
Asian populations, whereas data from other Asian countries 
are scarce. This study was conducted to validate the associa-
tions between the three SNPs, Y402H and I62V in CFH and 
A69S in the ARMS2 genes, and PCV in a Thai population. 
Since the Asian population comprises various ethnic groups 
that may differ in physical appearance, lifestyle, culture, 
religion, socioeconomic status, and genetic background,11 
the results were compared with the compiled data of studies 
from other Asian populations. The results obtained in this 
study should provide an insight into the genotypic manifes-
tations of PCV with additional data from a Southeast Asian 
population.
Methods
Participants
This study was conducted under approval of the   Ethical 
Committee on Research Involving Human Subjects of 
Rajavithi Hospital, Bangkok, Thailand. All participants 
gave written informed consent. A total of 119 patients with 
PCV and 173 controls were enrolled at the Eye Clinic of the 
same institute.
The inclusion criteria for PCV were: (1) Thai native; 
(2) having clinical manifestations of PCV , such as the pres-
ence of orange-red subretinal nodules, hemorrhagic retinal 
pigment epithelial detachment, subretinal hemorrhage, or 
intraretinal or subretinal fluid with exudates; and (3)   having 
a branching vascular network with terminal polypoidal 
dilation of choroidal vessels identified by indocyanine 
green angiography (ICGA). The polyps identified in ICGA 
should correspond with the orange nodules found in clini-
cal examination. The inclusion criteria for controls were: 
(1) Thai native; (2) age $50 years; (3) absence of serious 
systemic or known genetic-influenced diseases such as can-
cer, diabetes mellitus, and glaucoma; and (4) clinical absence 
of diseases of the vitreous, retina, retinal pigment epithelium 
and choroid, especially drusen, or retinal pigment epithelial 
abnormality.
The exclusion criteria for both groups were: (1)   relatives 
of any enrolled patients with PCV or controls, (2) any 
  ethnicity other than Thai, (3) any participants whose parents 
were not born in Thailand, and (4) any participants who did 
not sign the consent form.
Each participant underwent a comprehensive   ophthalmic 
evaluation using a slit lamp biomicroscope including dilated 
fundus examination and color fundus photography. All 
participants with PCV further underwent optical   coherent 
tomography and simultaneous fluorescein and ICGA using 
a scanning laser ophthalmoscope (Heidelberg Retinal 
Angiography II®, Heidelberg, Germany) to confirm the 
diagnosis.
genotyping
The genomic DNA was extracted from buffy coat using 
Compact Nucleic Acid Isolation Kit (MagNA Pure® Compact 
System, Roche Diagnostics, Mannheim, Germany). DNA 
concentration was measured and diluted to the final concen-
tration of 50 ng/µL using a spectrophotometer.
The genotyping of the rs1061170 (Y402H), the 
rs800292 (I62V), and the rs10490924 (A69S) polymor-
phism were performed in a 480 LightCycler® instrument 
(Roche Diagnostics) using a commercial real-time assay 
(LightMix®, Roche Diagnostics). A 10 µL reaction mix-
ture was prepared in a 96-well polymerase chain reaction 
(PCR) plate containing 50 ng genomic DNA, 0.5 µL for 
probe-primers mix (LightMix for the detection of human 
SNPs, TIB MOLBIOL GmbH, Berlin, Germany), 1 µL 
2X LightCycler® FastStart DNA Master HybProbe (Roche 
Diagnostics), 2.7 µL deoxyribonuclease (DNase)-free water 
(PCR-grade), and processed according to the manufac-
turer’s instructions (Roche Diagnostics). Real-time PCR 
of each SNP was performed by an initial denaturation at 
95°C for 10 minutes, followed by 45 cycles of 95°C for 
10 seconds, 60°C for 10 seconds, and 72°C for 15 seconds. 
In order to determine the melting points after the amplifica-
tion phase, a melting curve analysis was performed at 95°C 
for 30 seconds and at 40°C for 20 minutes, followed by a 
slow heating at the rate of 0.2°C per second until reach-
ing 75°C. The polymorphism was determined to have a 
specific melting point of 55°C for the risk and 62.5°C for 
the nonrisk allele.
In addition, nine blood samples were randomly selected 
for DNA sequencing analysis (Macrogen®, Seoul, Korea) to 
confirm the genotyping results.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
466
Chantaren et alClinical Ophthalmology 2012:6
Statistical analysis
The sample size was estimated using Quanto software12 with 
type 1 error set at 0.05 and power set at 80%. The minor allele 
frequency applied for this estimation was based on the lowest 
frequency of the three investigated SNPs in Asians reported 
in the literature, which was the frequency of Y402H of 0.05.13 
The prevalence of PCV was based on that of neovascular AMD 
in Thailand, 0.2%.14 PCV was estimated to be 23% of this 
prevalence15 or 0.05%. At least 85 participants were required 
in each study group using this estimation. The chi-square test 
was used for testing deviation of genotypic frequency from 
Hardy–Weinberg equilibrium. The Fisher’s exact test was used 
to test the allelic and genotypic associations of each SNP with 
PCV . Statistical significance was considered at P , 0.05.
Logistic regression analysis was used to estimate the odds 
ratio of having PCV for participants with the homozygous risk 
genotype compared with those who had the heterozygous, and 
homozygous nonrisk genotypes. Bonferroni correction was 
used for assessing the P-values obtained from these analyses.
For comparison with other Asian populations, data were 
compiled of association studies between the three SNPs and 
PCV in Asians published in the literature9,13,16–22 and calcu-
lated the association, allele frequency, and genotype distribu-
tion for each SNP using the same protocol. These compiled 
data gave sample sizes of 1291 PCVs and 2455 controls for 
Y402H, 713 PCVs and 1604 controls for I62V, and 747 PCVs 
and 1331 controls for A69S.
Results
A total of 97 patients with PCV and 102 normal controls were 
included for genetic analysis. No significant difference between 
these two groups was found for the demographic characteristics 
(Table 1). No significant deviation from the Hardy–Weinberg 
equilibrium was found for each SNP in either study group. 
The DNA sequencing results of all nine random blood samples 
confirmed the genotyping results of this study.
Risk allele frequency
In the cohorts used in this study, the frequency of the risk 
allele for each SNP, C, G, and T for Y402H, I62V, and A69S 
respectively, were found to be similar to that in the compiled 
data. In addition, the frequency of the risk allele of each SNP 
was significantly higher in participants with PCV than in 
controls in both datasets (Table 2).
Risk genotype
Data in Table 3 show that the genotype distribution in this 
study’s Thai population was similar to that in the compiled 
Asian population. The only exception was found for the 
frequency of the homozygous risk genotype (CC) of Y402H 
in the PCV group, which was higher in the present study’s 
population (3.1%) than in the compiled Asian population 
(0.7%). These frequencies, however, were very low in both 
populations.
Compared with having the homozygous nonrisk genotype 
(TT), having the heterozygous genotype Y402H (CT) signifi-
cantly increased the chance (by approximately three times) 
of having PCV . Individuals with the homozygous risk allele 
of I62V (GG) and A69S (TT) were approximately 4–5 times 
as likely to have PCV as those with the homozygous nonrisk 
allele (Table 4).
Discussion
This study showed that both Y402H and I62V polymorphisms 
in the CFH and the A69S in the ARMS2 genes were strongly 
associated with PCV in the Thai population. The confirmed 
genotyping results by DNA sequencing of all nine random 
blood samples suggested that the dataset was homogenous 
and unbiased. The strong association of the three SNPs was 
also observed in the compiled data of previously published 
studies in other Asian populations.
The I62V of CFH gene, rather than the Y402H, was 
initially believed to be the SNP associated with PCV in 
the Asian population.13,20 The results of this present study, 
in a Thai population, as well as those in the compiled data 
indicated that both I62V and Y402H SNPs were associated 
with PCV in Asians. This discordance might be due to the 
low frequency of Y402H in Asians compared with the higher 
frequency of I62V. There is no report on the association 
between I62V and PCV or AMD in Caucasians.
Interestingly, the frequency of the risk alleles of the 
Y402H and A69S in Asian patients with PCV may be different 
from that in Caucasian patients with PCV . The frequencies of 
the risk allele C of the Y402H in PCVs, 15.0% in the present 
study and 10.3% in the compiled data, were much lower than 
that in a cohort of subjects with PCV of European descent 
in the United States, which was 49.1%.10 This is also true 
for the risk allele T of the A69S. These allele frequencies in 
Table 1 Demographic characteristic of the study population
PCV  
(n = 97)
Controls  
(n = 102)
P-value
gender (male/female) 48/49 50/52 0.948a
Mean age ± SD (years) 62.9 ± 8.9 62.2 ± 7.6 0.595b
Age range (years) 42–87 50–86
Notes: aBy z-test; bby independent t-test.
Abbreviations: PCV, polypoidal choroidal vasculopathy; SD, standard deviation.
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Asians with PCV (54.1% in the present study and 56.8% 
in the compiled data) were higher than those in Caucasians 
with PCV (31.8%).10
In addition, the minor allele frequency (the risk allele 
frequency in controls) in Asians may also be different from 
that in Caucasians. The data from this present study and the 
compiled data indicated that the frequency of the allele C of 
the Y402H in controls was approximately 6%.9,13,17,20 This is 
comparable to the frequency of the allele C in controls, 5.1%, 
from a meta-analysis of association between this SNP and 
AMD in Asians.23 A meta-analysis of association between 
this SNP and AMD in Caucasian populations,2 however, 
indicates a much higher frequency of this allele in controls, 
34.9%. For A69S, a meta-analysis of association between this 
SNP and AMD3 points out that the minor allele frequency is 
38.7% in Asians but 21.6% in Caucasians.
These data suggest that although the frequency of Y402H 
or A69S is not uniform in diverse populations, its attributed 
risk for AMD or PCV exists across them. This supports 
the notion that the genetic effects of disease-associated 
variants are usually similar across racial boundaries regard-
less of their diverse allelic frequency among different 
populations.24
Although PCV is different from neovascular AMD 
in many aspects, such as the affected age group and 
response to photodynamic therapy, both diseases share 
some   similarities. Both are diseases of abnormal choroidal 
  vessels, and both respond to anti-vascular endothelial growth 
factor   (anti-VEGF) agent by absorption of exudates and 
extravascular fluid.25,26 This response to anti-VEGF, along 
with evidence that elevated C-reactive protein (CRP) levels 
is strongly associated with both PCV and AMD,27 suggests 
that inflammation plays a role in both diseases.
CFH is a critical negative regulator of complement 
activation and inflammation. The Y402H variant is located 
within complement control protein 7, one of the complement 
Table 2 The allele frequency for each single nucleotide polymorphism in this study and other studies in Asians
PCV Controls P-value Odds ratio 
(95% CI) N Ca T N Ca T
Rs1061170 (Y402H)
Current study 97 29 (15.0%) 165 (85.1%) 102 11 (5.4%) 193 (94.6%) 0.0023 3.081 (1.493–6.360)
Compiled  
studies
1291 266 (10.3%) 2316 (89.7%) 2455 314 (6.4%) 4596 (93.6%) ,0.0001 2.467 (2.046–2.973)
gotoh et al19 204 47 (11.5%) 361 (88.5%) n/A n/A n/A n/A n/A
Lee et al20 72 10 (6.9%) 134 (93.1%) 93 10 (5.4%) 176 (94.6%) 0.6438 1.31 (0.47–3.62)
Kondo et al13 130 23 (8.8%) 237 (91.2%) 173 18 (5.2%) 328 (94.8%) 0.0770 1.77 (0.93–3.35)
Hayashi et al9,b 510 106 (10.4%) 914 (89.6%) 1342 176 (6.6%) 2508 (93.4%) 9.73 × 10-5 n/A
nakanishi et al17 375 80 (10.7%) 670 (89.3%) 847 110 (6.5%) 1584 (93.5%) n/A n/A
N Ga A N Ga A
Rs800292 (I62V)
Current study 97 139 (71.7%) 55 (28.4%) 102 117 (57.4%) 87 (42.7%) 0.0034 1.879 (1.238–2.854)
Compiled  
studies
713 1072 (75.2%) 354 (24.8%) 1604 1871 (58.3%) 1337 (41.7%) ,0.0001 2.164 (1.883–2.487)
Lee et al20 72 109 (75.7%) 35 (24.3%) 93 113 (60.8%) 73 (39.2%) 0.0045 2.01 (1.21–3.36)
Kondo et al13 130 201 (77.3%) 59 (22.7%) 173 197 (56.9%) 149 (43.1%) 1.7 × 10-7 2.58 (1.80–3.69)
Hayashi et al9,b 511 762 (74.6%) 260 (25.4%) 1338 1561 (58.3%) 1115 (41.7%) n/A n/A
N Ta G N Ta G
Rs10490924 (A69S)
Current study 97 105 (54.1%) 89 (45.9%) 102 76 (37.3%) 128 (62.8%) 0.0008 1.987 (1.331–2.960)
Compiled  
studies
747 849 (56.8%) 645 (43.2%) 1331 980 (36.8%) 1682 (63.2%) ,0.0001 2.259 
(1.985–2.571)
Kondo et al18 76 95 (62.5%) 57 (37.5%) 94 71 (37.8%) 117 (62.2%) 5.7 × 10-6 n/A
Lee et al20 72 80 (55.6%) 64 (44.4%) 93 72 (38.7%) 114 (61.3%) 0.0027 1.98 (1.24–3.15)
Sakurada et al21 109 139 (63.8%) 79 (36.2%) 85 60 (35.3%) 110 (64.7%) ,0.0001 3.2 (2.1–4.9)
gotoh et al22 55 61 (55.5%) 49 (44.5%) 74 60 (40.5%) 88 (59.5%) 0.0058 2.0 (1.21–3.29)
nakanishi et al17 375 418 (55.7%) 332 (44.3%) 847 627 (37.0%) 1067 (63.0%) n/A n/A
Fuse et al16 60 56 (46.7%) 64 (53.3%) 138 90 (32.6%) 186 (67.4%) 0.0077 1.80 (1.17–2.80)
Notes: P-values by Fisher’s exact test; aindicates the risk alleles; bthe allele frequency was calculated from the reported genotype frequency.
Abbreviations: PCV, polypoidal choroidal vasculopathy; CI, confidence interval.
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control protein modules that contain binding sites for CRP.28 
Previous biological studies have shown that the risk allele 
variants of Y402H have reduced affinity on the binding to 
CRP.29 This may indicate that both AMD and PCV share 
the same genetic risks manifested by dysregulation of the 
complement system.
The relationship between A69S and AMD or PCV is 
not well understood. Earlier studies propose that the altered 
  function of the putative mitochondrial protein LOC387715/
ARMS2 by A69S substitution increases the susceptibility to the 
aging-associated degeneration of macular photoreceptors.30 
Another study, however, suggests that ARMS2 might not confer 
Table 3 The genotype distribution for each single nucleotide polymorphism in this study and other studies in Asians
PCV Controls P-value
CC CT TT CC CT TT
Rs1061170 (Y402H)
Current study 3 (3.1%) 23 (23.7%) 71 (73.2%) 0 (0%) 11 (10.8%) 91 (89.2%) 0.002
Compiled studies 8 (0.7%) 227 (19.5%) 926 (79.8%) 14 (0.6%) 268 (11.7%) 2000 (87.6%) ,0.001
gotoh et al19 2 (1.0%) 43 (21.1%) 159 (77.9%) n/A n/A n/A n/A
Lee et al20 0 (0%) 10 (13.9%) 62 (86.1%) 1 (1.1%) 8 (8.6%) 84 (90.3%) n/A
Hayashi et al9 5 (1.0%) 96 (18.8%) 409 (80.2%) 8 (0.6%) 160 (11.9%) 1174 (87.5%) n/A
nakanishi et al17 1 (0.2%) 78 (20.8%) 296 (79.0%) 5 (0.6%) 100 (11.8%) 742 (87.6%) 3.4 × 10-4
GG GA AA GG GA AA
Rs800292 (I62V)
Current study 46 (47.4%) 47 (48.5%) 4 (4.1%) 29 (28.5%) 59 (57.8%) 14 (13.7%) 0.005
Compiled studies 331 (56.8%) 209 (35.8%) 43 (7.4%) 492 (34.4%) 690 (48.2%) 249 (17.4%) ,0.001
Lee et al20 41 (56.9%) 27 (37.5%) 4 (5.6%) 36 (38.7%) 41 (44.1%) 16 (17.2%) 0.0175
Hayashi et al9 290 (56.8%) 182 (35.6%) 39 (7.6%) 456 (34.1%) 649 (48.5%) 233 (17.4%) n/A
TT GT GG TT GT GG
Rs10490924 (A69S)
Current study 2 (33.0%) 1 (42.3%) 24 (24.7%) 13 (12.8%) 50 (49%) 39 (38.2%) 0.002
Compiled studies 270 (36.1%) 309 (41.4%) 168 (22.4%) 182 (13.7%) 616 (46.3%) 533 (40.0%) ,0.001
Kondo et al18 31 (40.8%) 33 (43.4%) 12 (15.8%) 15 (16.0%) 41 (43.6%) 38 (40.4%) n/A
Lee et al20 25 (34.7%) 30 (41.7%) 17 (23.6%) 12 (12.9%) 48 (51.6%) 33 (35.5%) 0.0034
Sakurada et al21 45 (41.3%) 49 (44.9%) 15 (13.8%) 14 (16.5%) 32 (37.6%) 39 (45.9%) ,0.0001
gotoh et al22 18 (32.7%) 25 (45.5%) 12 (21.8%) 12 (16.2%) 36 (48.6%) 26 (35.1%) n/A
nakanishi et al17 133 (35.5%) 152 (40.5%) 90 (24.0%) 113 (13.3%) 401 (47.3%) 333 (39.3%) 1.6 × 10-14
Fuse et al16 18 (30.0%) 20 (33.3%) 22 (36.7%) 16 (11.6%) 58 (42.0%) 64 (46.4%) 0.0069
Note: P-value by Fisher’s exact test.
Abbreviation: PCV, polypoidal choroidal vasculopathy.
Table 4 The likelihood of homozygous or heterozygous risk genotype having PCV in this study and in the compiled data from other 
studies in Asians
Paired genotype Current study Compiled studies
P-value Odds ratio P-value Odds ratio
Rs1061170 
(Y402H)
CC vs TT 0.839 8.96 (0.46–176.24) 0.649 1.234 (0.516–2.952)
CT vs TT 0.006 2.974 (1.364–6.488) ,0.001 1.829 (1.508–2.219)
CC vs CT 0.869 3.43 (0.16–72.04) 0.513 0.675 (0.278–1.637)
Rs800292 
(I62V)
GG vs AA 0.005 5.5514 (1.665–18.513) ,0.001 3.896 (2.739–5.542)
gA vs AA 0.087 2.7829 (0.861–9.031) 0.002 1.754 (1.225–2.511)
GG vs gA 0.025 1.991 (1.090–3.636) ,0.001 2.221 (1.804–2.735)
Rs10490924 
(A69S)
TT vs gg 0.001 4.0 (1.760–9.091) ,0.001 4.707 (3.645–6.078)
Tg vs gg 0.390 1.333 (0.692–2.565) ,0.001 1.591 (1.276–1.985)
TT vs Tg 0.005 3.002 (1.396–6.454) ,0.001 2.957 (2.344–3.731)
Notes: Logistic regression analysis was used to test the likelihood of homozygous or heterozygous risk genotype having PCV when paired with homozygous nonrisk 
genotype; odds ratios indicate significance at P , 0.0167 (0.05/3, Bonferroni correction); the homozygous risk genotypes are in bold; the studies included in the compiled 
data are listed in Table 3. 
Abbreviations: PCV, polypoidal choroidal vasculopathy; vs, versus.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
469
CFH and ARMS2 and PCVClinical Ophthalmology 2012:6
risk to AMD through the mitochondrial pathway.31 Additional 
analysis of the LOC387715/ARMS2 protein with Ala or Ser 
codon 69 and its function in vivo are needed to better under-
stand its contribution to PCV or AMD pathogenesis.
Limitations in this study include the assessments of only 
three major SNPs associated with AMD. Other SNPs may also 
be associated with PCV . To the authors’ knowledge there has 
been no genome-wide study to document other PCV-associated 
SNPs that may not be associated with AMD. The compiled 
data from previously published studies were set up only for 
comparison with the results of this study. The aim was not to 
conduct a meta-analysis of association between the three SNPs 
and PCV; therefore, there were no strong criteria for inclusion 
and exclusion of the studies into the compiled data. Although 
the results of this study suggest a trend toward association 
between the three SNPs and PCV , more data from other Asian 
populations and other ethnic groups are necessary.
Cigarette smoking has been found to be associated with 
PCV , and there was possible interaction between the Y402H 
and cigarette smoking on PCV .17 However, some studies on 
interaction between cigarette smoking and SNPs in AMD 
showed contradictory results.32–35 Smoking history was sur-
veyed in the present study’s participants, but the data were 
so varied and unreliable that they were not used for analysis. 
This is another limitation of this study.
In conclusion, the major AMD-susceptibility genes, 
CFH with Y402H and I62V and ARMS2 with A69S, are 
associated with PCV in a Thai population. The results are 
in concordance with those from the compiled data obtained 
from previous association studies in other Asian   populations. 
This suggests that AMD and PCV may share the same 
genetic predisposition. A genome-wide association study for 
PCV will improve the identification of other possible PCV 
  susceptibility genes. This genetic data will eventually lead to 
a better understanding of the pathogenesis of PCV .
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